Louise Grode1, Thomas Møller Jensen1, Tina Parkner2, Inge Errebo Agerholm3, Peter Humaidan4,5, Bodil Hammer Bech6, Cecilia Ramlau-Hansen6. 1. Department of Medicine, Horsens Regional Hospital, Horsens, Denmark. 2. Department of Clinical Biochemistry, Arhus University Hospital, Aarhus, Denmark. 3. Department of Clinical Biochemistry, Arhus University Hospital, Origio, Måløv, Denmark. 4. Fertility Clinic, Skive Regional Hospital, Skive, Denmark. 5. Faculty of Health, Aarhus University, Aarhus, Denmark. 6. Department of Public Health, Aarhus University, Aarhus, Denmark.
Abstract
BACKGROUND: Screening for celiac disease among infertile patients has been suggested. Several rapid point-of-care (POC) tests aimed at detecting celiac disease antibodies have been developed. It has been suggested that these POC tests can be implemented as a replacement for standard laboratory tests. OBJECTIVE: To evaluate the diagnostic accuracy of a POC test (Simtomax®) that detects celiac disease antibodies compared with standard laboratory tests when screening for celiac disease among patients referred for fertility treatment in 2 Danish fertility clinics. METHODS: Serum samples were analyzed for IgA anti-tissue transglutaminase (TGA) as the reference standard test with a cutoff of ≥7 kU/L and by the index POC test based on IgA and IgG antibodies against deamidated gliadin peptides (DGP). In IgA deficiency, the reference standard test was IgG DGP with a cutoff of ≥7 kU/L. Participants answered a questionnaire on gluten intake, symptoms, and risk factors. Diagnostic confirmation was made by duodenal biopsies. IgA TGA/IgG DGP were used as the reference standard to calculate positive and negative predictive values. RESULTS: A total of 622 men and women (51.6%) were enrolled during 2015. The reference standard IgA TGA/IgG DGP was positive in 7 participants (1.1% [95% CI 0.5-2.3]) and the POC test was positive in 84 participants (13.5% [95% CI 10.9-16.4]), 3 of whom also had positive reference standard tests. This yields a sensitivity of the index POC test of 42.9% (95% CI 9.9-81.6) and a specificity of 86.8% (95% CI 83.9-89.4). Positive and negative predictive values were 3.57% (95% CI 0.7-10.1) and 99.3% (95% CI 98.1-99.8). CONCLUSION: The sensitivity of the POC test was low; however, the specificity was moderately good. The POC test had a high negative predictive value in this low prevalent population but missed 1 patient with biopsy-confirmed celiac disease. However, because of many false-positive tests, it cannot be recommended as replacement for standard laboratory tests but rather as a triage test to decide if the standard serology tests should be performed.
BACKGROUND: Screening for celiac disease among infertile patients has been suggested. Several rapid point-of-care (POC) tests aimed at detecting celiac disease antibodies have been developed. It has been suggested that these POC tests can be implemented as a replacement for standard laboratory tests. OBJECTIVE: To evaluate the diagnostic accuracy of a POC test (Simtomax®) that detects celiac disease antibodies compared with standard laboratory tests when screening for celiac disease among patients referred for fertility treatment in 2 Danish fertility clinics. METHODS: Serum samples were analyzed for IgA anti-tissue transglutaminase (TGA) as the reference standard test with a cutoff of ≥7 kU/L and by the index POC test based on IgA and IgG antibodies against deamidated gliadin peptides (DGP). In IgA deficiency, the reference standard test was IgG DGP with a cutoff of ≥7 kU/L. Participants answered a questionnaire on gluten intake, symptoms, and risk factors. Diagnostic confirmation was made by duodenal biopsies. IgA TGA/IgG DGP were used as the reference standard to calculate positive and negative predictive values. RESULTS: A total of 622 men and women (51.6%) were enrolled during 2015. The reference standard IgA TGA/IgG DGP was positive in 7 participants (1.1% [95% CI 0.5-2.3]) and the POC test was positive in 84 participants (13.5% [95% CI 10.9-16.4]), 3 of whom also had positive reference standard tests. This yields a sensitivity of the index POC test of 42.9% (95% CI 9.9-81.6) and a specificity of 86.8% (95% CI 83.9-89.4). Positive and negative predictive values were 3.57% (95% CI 0.7-10.1) and 99.3% (95% CI 98.1-99.8). CONCLUSION: The sensitivity of the POC test was low; however, the specificity was moderately good. The POC test had a high negative predictive value in this low prevalent population but missed 1 patient with biopsy-confirmed celiac disease. However, because of many false-positive tests, it cannot be recommended as replacement for standard laboratory tests but rather as a triage test to decide if the standard serology tests should be performed.
Entities:
Keywords:
Celiac disease; Early detection; Gluten intolerance; Rapid test; Screening
Authors: Daniëlle A W M van der Windt; Petra Jellema; Chris J Mulder; C M Frank Kneepkens; Henriëtte E van der Horst Journal: JAMA Date: 2010-05-05 Impact factor: 56.272
Authors: Gian Mario Tiboni; Maria Grazia de Vita; Raffaella Faricelli; Franca Giampietro; Marco Liberati Journal: Hum Reprod Date: 2005-09-19 Impact factor: 6.918
Authors: Alberto Rubio-Tapia; Mussarat W Rahim; Jacalyn A See; Brian D Lahr; Tsung-Teh Wu; Joseph A Murray Journal: Am J Gastroenterol Date: 2010-02-09 Impact factor: 10.864
Authors: A S Khashan; T B Henriksen; P B Mortensen; R McNamee; F P McCarthy; M G Pedersen; L C Kenny Journal: Hum Reprod Date: 2009-11-24 Impact factor: 6.918